Skip to main content

Scholarship opportunity for an undergrad with albinism

I just got this e-mail from NOAH - the National Organization for Albinism and Hypopigmentation. I'm am thrilled to pass it along!

NOAH's Michael J. McGowan Leadership Scholarship Award



2012 Application is now Available!


--------------------------------------------------------------------------------


The Michael J. McGowan Leadership Scholarship Award was established in 2008 on behalf of the National Organization for Albinism and Hypopigmentation (NOAH) to recognize leadership and empower young people with albinism. NOAH will award one scholarship annually to a NOAH member with albiism residing in the U.S. or Canada who is enrolled in an undergraduate program at an institution of higher education in the U.S. or Canada. The intent is to enhance educational opportunities for students with albinism while celebrating dedication and outstanding leadership qualities similar to those exhibited by NOAH's current and past leaders. The 2012 scholarship award will be $3,000.


--------------------------------------------------------------------------------


To apply, complete the online application then submit the following:


•Your personal statement (500 words or less)


•An eye report documenting a diagnosis of albinism


•At least two (2) letters of recommendation from non-family members


•Your academic transcript (including SAT/ACT scores, if applicable)


•A letter of acceptance to or proof of enrollment at an institution of higher learning






--------------------------------------------------------------------------------


Application materials for the 2012 McGowan Scholarship must be RECEIVED by May 1, 2012.










Send all application materials to:


NOAH McGowan Scholarship


PO Box 959


East Hampstead, NH 03826-0959


Fax: 800-648-2310


Email: scholarship@albinism.org


















--------------------------------------------------------------------------------


Please contact NOAH's Scholarship Committee with any questions at scholarship@albinism.org or 800-473-2310 (U.S. and Canada).










Applicants will receive notification of the award committee's decision on or around June 1, 2012.


















--------------------------------------------------------------------------------


Labels:

Comments

Post a Comment

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for...
1 comment
Read more

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria...
Post a Comment
Read more

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.
Post a Comment
Read more